A man sits at his kitchen table suffused with disappointment, his breakfast of scrambled eggs, toast, bacon, and coffee, prepared and long-since cold, sits in front of him. He stares vacantly at his hands, the left hand gripping a magnifying glass, the right one, his insulin pump. After several attempts to read the information on his insulin pump screen, he has come to the realization that his vision has finally regressed to a point that even with the help of a magnifier, he cannot. With this knowledge, he knows that he will no longer be able to administer his insulin regimen without assistance. He is a man who has always valued his ability to face adversity and to take care of problems on his own. Although he knew the time would come, he …show more content…
“1976 … The first insulin pumps were invented … 1978 Portable insulin pumps are introduced and researchers achieve normal blood glucose levels in patients using them. But, due to their large size, they are impractical at this time” (ADA). Even with all of its improvements over the years, including making it small enough to carry in a pocket or on a belt clip, the technology for talking capability is considerably new and has not as yet been merged into pump programming. The insulin pump works just as well for the visually impaired as for others. The concern though, is that it is not accessible for those that cannot read the screens of information, to control the setup and delivery of insulin. These screens give information detailing basal rate, the amount of bolus insulin the user wishes to administer, information, which reminds the user of the last bolus delivery, and other pertinent information. There is a large number of visually impaired that can make use of a talking insulin …show more content…
At an exponential rate of increase, the number of diabetics with visual impairment in 2030 will reach 6.8 million in the U.S. alone, which is an increase of 70 percent. If 20.6 percent of that number use insulin to control glucose levels that means a potential of 1.4 million visually impaired customers in the U.S. The need for the product is easy to see, considering the possible national and international sales of the item. If demand were the only consideration, this evidence might suffice; of course, there is also the issue of cost of production
A review of the records reveals the member to be an adult male with a birth date of 02/26/1952. The member has a diagnosis of Type 1 diabetes. The member’s treating provider, Adeniyi Odugbesan, MD recommended a replacement insulin pump (E0784).
He told me that he was diagnosed with type 2 diabetes in December 2010. Since his doctor prescribed rapid acting insulin for his diabetes, I asked him if it is acceptable to talk about his medical condition in front of his family. He gave me consent to talk about his medical problems in front of his wife and children. I suggested to him the need to take his insulin shot right before eating a meal. I informed him about the insulin medications that he was taking which was lispro. It has an onset of 10 to 30 minutes, peak time of 30 to 3 hours and a duration of 3 to 5 hours. Furthermore, I emphasized the need for him to eat a balanced diet, and the importance of exercise. I encouraged him to eat small amounts of carbohydrates during 30 minutes of exercise to prevent hypoglycemia. I also taught him that the signs and symptoms of hypoglycemia are tachycardia, irritation, excessive hunger, restless, diaphoretic and depression. He told me that he did not like to walk and do any activity besides going to his job. I brought some articles about how eating healthy, taking his medication, and regular exercise has shown to prevent, slow down the progressive process on type 2 diabetes. I suggested to him to start walking around his neighborhood, and later he could find a support group of friends can walk together with. For instance, Lewis, Sharon, Margaret Heitkemper, and Linda Bucher. "Medical-Surgical Nursing: Assessment and Management of Clinical
Over this last week, I have received a patient named Sherman “Red” Yoder. He is an 80-year-old male farmer, who lives alone in the farmhouse that he had grown up in. Red was married for 50 years and has been a widow now for 10 years. Red has one son, Jon, who takes care of the farmhouse and the land. He has one daughter-in-law, Judy, who is in involved with his care. Red was diagnosed with diabetes six months ago. Diabetes mellitus is a chronic condition that affects your body 's ability to use the energy found in food. As of only a few weeks ago, Red has been managing his diabetes with insulin. Insulin is a hormone that controls blood sugar. Before he began using insulin, he managed his diabetes with oral medication. After carefully assessing Red’s chronic illness, diabetes, many red flags were presented that could interfere with his management. In turn, this would cause further complications.
Another example, people with hearing disability may use hearing aids. They are battery-powered electronic devices with small microphones to pick up and increase the volume of sound received by a person. Also, text phones, relay systems and minicoms may be used for people who are deaf or hard of hearing.
Even though there are some parts that Eli Lilly fail on it but it try hard to understand what their customer really need. Eli Lilly found out that customer would willing to use their new product if they did some change to it such as more easy for customers to using new product or using other technology instead of need to inject. And more important is that Eli Lilly found out that most of their customers don’t have enough of information about diabetes care. So Eli Lilly set up an Controlled Diabetes Services program (CDS) which educating people and building a community of patients the value of their insulin therapy. I think Eli Lilly made a good decision about setting up CDS which can indirectly understand what their customers need and allow more people have more opportunity to get to know their product and use their product. Focusing on know their customer and educating their customer will let more and more people know their new product and form a habit of using their new product. If CDS successfully then Eli Lilly new product such as Match and Insulin pens will have less problem when it sales on the market.
The American Diabetes Association (2004) defines diabetes as a subset of metabolic diseases associated with hyperglycemia secondary to insulin failing to release, act, or both. Complications related to chronic diabetes can be detrimental to one’s health including but not limited to: heart disease, stroke, kidney disease, amputations, blindness, and other optical diseases. Furthermore, the prevalence of diabetes is rising at an astronomical rate within the United States as well as internationally. According to the Center for Disease Control and Prevention (CDC) (2016) an estimated 29 million people suffer with diabetes and 86 million are prediabetic within the United States (US). Without major interventions from the healthcare community,
Learning objective #3: (Psychomotor) patient will demonstrate ability to self-administer Insulin with little, or no prompts.
We live in an era of rapid technological change, and this environment, undoubtfully changes the human health. Diabetes is one of the most widespread diseases, unfortunately. Therefore, there is a pressing need to inform people about healthy ways of living and a caring approach to their health. The American Diabetes Association (ADA) is one of the organizations that try, to prevent diabetes and raise awareness on the disease in the US and around the world. Unfortunately, it has a set of weaknesses, which influence not only the work of the organization, but the general public’s opinion of it as well.
Diabetes is a chronic illness that requires continuous medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications[ ].
Peering into the window of Da Vita dialysis, an elderly man sits patiently. His patience is not from the fact that he has no place to go afterwards; his schedule was clear. His patience came from the fact that he can bare the wait in the room, because he knows down the hall the nurse will be re-puncturing his forearm to administer the hemodialysis. It was his third time coming in this week, which meant he wouldn 't be back until next week. Of course, when he looks at the bruising on his arm, it 's not next week but yet just couple of days of freedom. His name is called, and he gets up. It will be 4 hours of hemodialysis before he is released. The release is of course temporary as he must return for dialysis in due time. Only one thing can truly free him.
I know that you are trying to help, but I need you to know that my life is much more complicated than the aspects that I let you see. Diabetes can be a very degenerative disease. Insulin helps us survive, but it doesn’t cure us. If we don’t live the textbook (nearly impossible, saintly) life of a diabetic, the consequences can be devastating. One-third of our lives could be cut-off. We can lose circulation in our feet and hands. Our organs can slowly corrode, and blindness is an imminent dread for 1 in 10 diabetics who don’t keep their blood-sugar under constant control.
2.1 When communicating with individuals with sight loss there are a number of factors you need to consider. You need to make it clear that you are speaking to them and not someone else. They can not see you to read your body language so you need to be clear about your meanings and directions. Also a noisy environment can make it difficult for them to concerntrate on your voice.
On November 15, 2017, I attended a professional meeting called “Think Like A Pancreas: A Practical Guide to Managing Diabetes with Insulin.” The sponsors for this meeting were SNDA and CVD. The speaker who presented at the meeting was Gary Scheiner Ms, CDE. He is an author of the book “Think Like A Pancreas: A Practical Guide to Managing Diabetes with Insulin.” The general objective for this meeting helped people gain more knowledge about diabetes, and learned more from author personal experiences with type I diabetes. After I attended this meeting, I become more knowledgeable about diabetes. I have a chance to learn more about diabetes nutrition, different type of medications, and many tools that are available for diabetes patients to keep track on the blood glucose.
Imagine if you couldn 't see anything. You are seized by darkness and enclosed by a constant perception to look. You are blind as a bat and the colors you see in this world are only the ones you have imagined. The world would be a very contrasting place. Powerless to read a thrilling book and incompetent to do the most delighted hobbies. Unable to understand the appearance of your self and others, where everything you see is what your wild imagine has led you to believe. This is the world of the blind. I will be telling you about the word-wide famous, one and only system that has helped countless visionless people. The Braille system!
Diabetes is a systemic disease caused by a decrease in the secretion of insulin or reduced sensitivity or responsiveness to insulin by target tissue. (Beale, et al., 2011) The incidence of diabetes is growing rapidly in the United States and worldwide. An estimated 347 million people around the world are afflicted with diabetes. (Whalen, et al., 2012) According to World Health Organization (WHO), Diabetes prevalence among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. It is the major cause of blindness, kidney failure, heart attack, stroke and limbic amputation. World Health Organization (WHO) projects that diabetes will be the 7th leading cause of death in 2030. It is a complex and costly disease that can affect nearly every organ in the body and result in devastating consequences. The leading cause of non-traumatic lower extremity amputations, renal failure, and blindness in working-age adults, diabetes is also a major cause of premature mortality, stroke, cardiovascular disease, peripheral vascular disease, congenital malformations, perinatal mortality, and disability. (Cefalu, 2000) Insulin therapy and oral hypoglycemic agents have demonstrated improvement in glycaemic control. However, Insulin therapy has some disadvantages such as ineffectiveness following oral administration, short shelf life, of the need for constant refrigeration, and fatal hypoglycaemia, in the event of excess dosage.